Sanguine BioSciences

Product

We accelerate Personalized Medicine discovery by providing biological and clinical data to researchers through a direct-to-patient platform that empowers patients in drug and biomarker research.

Thousands of patients’ data are needed to develop each new drug and diagnostic, and our model enables us to collect, and ultimately provide biological and clinical data much more quickly and less costly than current market standards.

Founders

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Kaley Zeitouni

Co-founder & VP of Patient Relations of Sanguine BioSciences
David Winternheimer

V.P. at Sanguine BioSciences Inc.
Sascha Hasan

Chief Scientific Officer - Sanguine Biosciences
Carlyn Crisostomo

Vice President, Clinical Strategy & Operations at Sanguine Biosciences, Inc.
Brian Neman

Founder & CEO @sanguine-biosciences, USC Renaissance Scholar - Biotechnology, Healthcare, Entrepreneurship

Previous Investors

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Investment Amount

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Bryce Knight
Unconfirmed

Incubator

Incubated by

Cancel

Advisors

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Nate Snyder

Owner, Redyns Medical
Timothy Triche,

Professor at USC/CHLA
David Brandt

at
Michael Lebow,

Director at Michael Lebow, Ph.D.

References

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Nate Snyder

Owner, Redyns Medical
Lorenz Ng

Managing Partner at Global Ng Associates LLC

Referrer

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Francisco Diaz-Mitoma

Founder of Titan Gaming; Co-Founder of VIRURL. Canadian living in LA.

“> 70 returning customers since launch in December 2011”

21 days ago

4 Comments

25 Followers

Timothy Triche, To assist the company in its efforts to provide personalized medicine, an area of significant interest to me.

1 month ago

Lorenz Ng I believe in Sanguine's advocacy-based vision of having patients as an equal partner in the R&D process. I applaud CEO Brian Neman's passion and commitment to transform that vision into reality

21 days ago

Nate Snyder The patient bio-specimen collection method that Sanguine has developed is more efficient and generates more patient data than traditional methods. I have toured the lab, spent a lot of time with CEO Brian Neman and his team and have become convinced that Sanguine has the potential to dramatically improve the personalized medicine R&D process.

21 days ago

Michael Lebow, Sanguine has a valuable model and is receiving orders faster than thet can process them. The company is looking for market share and they are succeeding on a low cost model.

18 days ago

AngelList